alogliptin and metformin HC tablets
for oral use Initial U.S. Approval: 2013

KAZANO is a dipeptidyl-peptidase-4 (DPP-4) inhibitor and a biguanide combination product indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Facts about alogliptin and metformin Tablets

Approval Date:  2013
Proprietary Name:  KAZANO (alogliptin and metformin HCl) tablets
Active Ingredient(s):  alogliptin and metformin HCl
FDA-approved use:
Dosage Form:  Tablets: 12.5 mg alogliptin and 500 mg metformin HCl, 12.5 mg alogliptin and 1000 mg metformin HCl.
Medicine Approved By: Food and Drug Administration (FDA)
Manufacturer: Takeda Pharmaceuticals
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import “alogliptin and metformin Tablets” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

empagliflozin and linagliptin tablets
for oral use Initial U.S. Approval: 2015

Facts about empagliflozin and linagliptin tablets

Approval Date:  2015
Proprietary Name: GLYXAMBI (empagliflozin and linagliptin) tablets
Active Ingredient(s):  empagliflozin and linagliptin
FDA-approved use:
Dosage Form:  Tablets:  • 10 mg empagliflozin/5 mg linagliptin  • 25 mg empagliflozin/5 mg linagliptin
Medicine Approved By: Food and Drug Administration (FDA)
Manufacturer: Boehringer Ingelheim Pharmaceuticals, Inc
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import “empagliflozin and linagliptin tablets” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

exenatide Injection
Initial U.S. Approval: 2005

BYETTA is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Facts about exenatide Injection 

Approval Date:  2005
Proprietary Name:  BYETTA (exenatide) Injection
Active Ingredient(s):  exenatide
FDA-approved use: 2 diabetes mellitus.
Dosage Form:  BYETTA is supplied as 250 mcg/mL exenatide in:  • 5 mcg per dose, 60 doses, 1.2 mL prefilled pen • 10 mcg per dose, 60 doses, 2.4 mL prefilled pen.
Medicine Approved By: Food and Drug Administration (FDA)
Manufacturer: Amylin Pharmaceuticals, Inc.
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Full Support:

IPN, Delhi can help with your prescription of the Registered Medical Practitioner (RMP) to get access. Based on your input information received, a step by step guide on how we can help you legally and safely import a medicine “exenatide Injection” will be provided.

tirzepatide Injection,
for subcutaneous use Initial U.S. Approval: 2022

As specified in the prescribing information, tirzepatide Injection is indicated for the treatment of diabetes.  MOUNJARO is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Facts about tirzepatide injection

Approval Date: 5/13/2022
Proprietary Name: Mounjaro
Active Ingredient(s): tirzepatide
FDA-approved use: To improve blood sugar control in diabetes, in addition to diet and exercise
Dosage Form: Injection: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg per 0.5 mL in single-dose pen
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import “tirzepatide injection” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.